With first drug trial underway, OnKure inks merger with Reneo Pharma to go public
OnKure Inc., a Boulder precision oncology company, and California-based Reneo Pharmaceuticals Inc. have agreed to a merger that would take OnKure public and provide a capital infusion.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Arca Biopharma has completed its merger with Oruka Therapeutics Inc.
-
Gogo Inc. (Nasdaq: GOGO), a Broomfield-based provider of broadband connectivity services for the business aviation…
-
A Larimer County District Court judge has appointed a receiver for North Shore Manor nursing…
-
Arca Biopharma's board of directors late last week approved a 1-for-12 reverse stock split in…
